Oncoclínicas do Brasil Serviços Médicos

Brazil's Aging Demographics And Digital Health Will Expand Oncology Care

AnalystHighTarget

Not Invested

Consensus Narrative from 8 Analysts

Published

19 Jul 25

Updated

15 Aug 25

AnalystHighTarget's Fair Value

R$9.00

40.3% undervalued

15 Aug

R$5.37

-16.7%

-4.4%

Author's Valuation

R$9.0

40.3% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

R$9.0

40.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.73%

Healthcare Services revenue growth rate

0.27%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

19.35%

Calculation

R$1.03b

Earnings '28

18.13x

PE Ratio '28

R$18.71b

Market Cap '28

R$18.71b

Market Cap '28

1.22b

No. shares '28

R$15.33

Share Price '28

R$15.33 Share Price '28

Discounted to 2025 @ 19.44% p.a.

R$9.00

Fair Value '25